Back to search

Article

Molecular pathological characteristics and tumour immune microenvironment of lung malignancies with RET rearrangement

2022-12-28

Abstract excerpt

<h4>Purpose: </h4> For patients with lung malignancies with RET rearrangement, the efficacy of immune checkpoint inhibitors is limited. The characteristics of the tumour immune microenvironment (TIME) and molecular pathological features of these patients have not been well elucidated. Methods The pathology and TIME characteristics of 29 patients with lung malignancies with RET rearrangement were retrospectively a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ce393463-14af-5957-8f53-892d99dc3be8
DOI
10.21203/rs.3.rs-2397760/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Molecular pathological characteristics and tumour immune microenvironment of lung malignancies with RET rearrangementDOI 10.21203/rs.3.rs-2397760/v1
Molecular and Histopathological Characterization of the Tumor Immune Microenvironment in Advanced Stage of Malignant Pleural MesotheliomaSemantic proximity
Integrated molecular characterization reveals potential therapeutic strategies for pulmonary sarcomatoid carcinoma.Semantic proximity
Remarkable response to pralsetinib in an advanced pulmonary sarcomatoid carcinoma patient harboring a KIF5B-RET rearrangement: A case reportSemantic proximity
Integrative genomic and transcriptomic profiling of pulmonary sarcomatoid carcinoma identifies molecular subtypes associated with distinct immune features and clinical outcomesSemantic proximity
Single-cell analysis reveals multicellular immune coordination and drug targets in driver-mutated NSCLCSemantic proximity
Molecular Landscape and Therapeutic Strategies of Lung Cancer Lineage PlasticitySemantic proximity
PD-L1, Vimentin and Ki-67 Acting as Immunotherapy Predictive Biomarkers in Pulmonary Carcinomas Transthoracic and Bronchial BiopsiesSemantic proximity
Expanding the Molecular Characterization of Thoracic Inflammatory Myofibroblastic Tumors beyond ALK Gene RearrangementsSemantic proximity
Immune biomarkers and response to checkpoint inhibition of BRAFV600 and BRAF non-V600 altered lung cancers.Semantic proximity
Association of genetic and immuno-characteristics with clinical outcomes in patients with RET-rearranged non-small cell lung cancer: a retrospective multicenter study.Semantic proximity
Tumor Microenvironment Properties are Associated With Low CD68-positive Cell Infiltration and Favorable Disease-free Survival in EGFR-mutant Lung Adenocarcinoma.Semantic proximity
Genetic drivers of tumor microenvironment and immunotherapy resistance in non-small cell lung cancer: the role of KEAP1 , SMARCA4 , and PTEN mutationsSemantic proximity
Select a neighboring publication to make it the new centre.